About Us

iCells International is a leading enterprise specializing in iPSC stem cell technology and gene editing services. Founded in 2016 by Jeff Qi Nianmin, Professor of Shanghai Jiao Tong University and former Senior Process Development Scientist at Bayer US, iCells International has been at the forefront of advancing scientific research and development, committed to addressing some of the most challenging issues in biomedicine.

Our mission is to provide comprehensive solutions for disease modeling, drug discovery, and cell therapy through innovative iPSC technologies and gene editing tools. The product line of iCells International encompasses a range of high-quality iPSC products that can be induced to differentiate into various cell types.

The R&D team at iCells International is composed of scientists with profound expertise in the fields of stem cell biology, gene editing, and regenerative medicine. They possess extensive experience in iPSC reprogramming, gene editing, cell differentiation, and the establishment of disease models. Utilizing cutting-edge technologies such as CRISPR/Cas9, iCells International is capable of performing efficient and precise gene editing on iPSCs, providing powerful tools for research and therapeutic applications.

iCells International is dedicated to offering highly customized services to meet the individual research needs of our clients. We focus on tailor-making iPSC cell lines, differentiation products, and gene editing services, as well as providing professional technical training and support. Our facilities meet international standards, ensuring that all products are manufactured under strict quality control.

Furthermore, iCells International is committed to integrating intellectual resources and outcomes from institutions, universities, and the industry, thereby greatly facilitating the development of innovative cell products and benefiting society. To this end, a network has been established that includes iCells International as well as several institutions or laboratories.

As your partner in the field of iPSC stem cell technology and gene editing, iCells International looks forward to embarking on a new chapter in life sciences with you.